Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (2009 - 2026)

Zimmer Biomet Holdings' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $238.3 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 30.58% year-over-year to $238.3 million in Q1 2026; TTM through Mar 2026 was -$197.5 million, a 251.81% decrease from a year earlier, with the FY2025 full-year figure at -$253.2 million, changed N/A from the prior year.
• Net Income towards Common Stockholders rose to $238.3 million in Q1 2026 per ZBH's latest filing, from -$820.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $419.7 million in Q4 2023 and bottomed at -$820.4 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $196.2 million (2023), against an average of $76.6 million.
• Across the five-year window, Net Income towards Common Stockholders slumped 1351.06% in 2022 and jumped 495.75% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$58.8 million in 2022, then surged by 813.78% to $419.7 million in 2023, then plunged by 229.78% to -$544.7 million in 2024, then slumped by 50.62% to -$820.4 million in 2025, then surged by 129.05% to $238.3 million in 2026.
• Per Business Quant, the three latest ZBH Net Income towards Common Stockholders figures stand at $238.3 million (Q1 2026), -$820.4 million (Q4 2025), and $231.2 million (Q3 2025).